Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease

Journal of Neuroimmunology

Volumn 172, Issue 1-2, 2006, Pages 175-181

  Stoeck, Katharina ^a   Bodemer, Monika ^a   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cerebrospinal fluid (CSF); Chemokines; Creutzfeldt Jakob disease (CJD); Cytokines; Prion disease

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SEIZURE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM DISEASES; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33244485505     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.10.008     Document Type: Article

References (43)

1. P. Beaudry, P. Cohen, J.P. Brandel, N. Delasnerie-Laupretre, S. Richard, J.M. Launay, and J.L. Laplanche 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Dement. Geriatr. Cogn. Disord. 10 1999 40 46
2. H. Budka, A. Aguzzi, P. Brown, J.M. Brucher, O. Bugiani, F. Gullotta, M. Haltia, J.J. Hauw, J.W. Ironside, and K. Jellinger Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol. 5 1995 459 466
3. I.L. Campbell, M. Eddleston, P. Kemper, M.B. Oldstone, and M.V. Hobbs Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie J. Virol. 68 1994 2383 2387
4. A. Chalazonitis, J. Kalberg, D.R. Twardzik, R.S. Morrison, and J.A. Kessler Transforming growth factor beta has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor Dev. Biol. 152 1992 121 132
5. M.C. Cheeran, S. Hu, S.L. Yager, G. Gekker, P.K. Peterson, and J.R. Lokensgard Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications J. Neurovirol. 7 2001 135 147
6. S.J. Dulkerian, L. Kilpatrick, A.T. Costarino Jr., L. McCawley, J. Fein, L. Corcoran, S. Zirin, and M.C. Harris Cytokine elevations in infants with bacterial and aseptic meningitis J. Pediatr. 126 1995 872 876
7. P. Eikelenboom, C. Bate, W.A. Van Gool, J.J. Hoozemans, J.M. Rozemuller, R. Veerhuis, and A. Williams Neuroinflammation in Alzheimer's disease and prion disease Glia 40 2002 232 239
8. S. Engelborghs, M. De Brabander, J. De Cree, R. D'Hooge, H. Geerts, H. Verhaegen, and P.P. De Deyn Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type Neurochem. Int. 34 1999 523 530
9. G.Z. Feuerstein, X. Wang, and F.C. Barone The role of cytokines in the neuropathology of stroke and neurotrauma Neuroimmunomodulation 5 1998 143 159
10. K.C. Flanders, R.F. Ren, and C.F. Lippa Transforming growth factor-betas in neurodegenerative disease Prog. Neurobiol. 54 1998 71 85
11. D. Galimberti, N. Schoonenboom, E. Scarpini, and P. Scheltens Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients Ann. Neurol. 53 2003 547 548
12. M. Glimaker, P. Kragsbjerg, M. Forsgren, and P. Olcen Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis J. Infect. Dis. 167 1993 882 889
13. A.J. Green, E.J. Thompson, G.E. Stewart, M. Zeidler, J.M. McKenzie, M.A. MacLeod, J.W. Ironside, R.G. Will, and R.S. Knight Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease J. Neurol. Neurosurg. Psychiatry 70 2001 744 748
14. H. Hampel, D. Schoen, M.J. Schwarz, H.U. Kotter, C. Schneider, T. Sunderland, R. Dukoff, J. Levy, F. Padberg, S. Stubner, K. Buch, N. Muller, and H.J. Moller Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease Neurosci. Lett. 228 1997 143 146
15. A. Harada, N. Sekido, T. Akahoshi, T. Wada, N. Mukaida, and K. Matsushima Essential involvement of interleukin-8 (IL-8) in acute inflammation J. Leukoc. Biol. 56 1994 559 564
16. S.L. Hauser, T.H. Doolittle, R. Lincoln, R.H. Brown, and C.A. Dinarello Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6 Neurology 40 1990 1735 1739
17. G. Hsich, K. Kinney, C.J. Gibbs, K.H. Lee, and M.G. Harrington The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies N. Engl. J. Med. 335 1996 924 930
18. W. Kelder, J.C. McArthur, T. Nance-Sproson, D. McClernon, and D.E. Griffin Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia Ann. Neurol. 44 1998 831 835
19. R. Kordek, V.R. Nerurkar, P.P. Liberski, S. Isaacson, R. Yanagihara, and D.C. Gajdusek Heightened expression of tumor necrosis factor alpha, interleukin 1-alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob Disease in mice Proc. Natl. Acad. Sci. U. S. A. 93 1996 9754 9758
20. B.R. Lane, K. Lore, P.J. Bock, J. Andersson, M.J. Coffey, R.M. Strieter, and D.M. Markovitz Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy J. Virol. 75 2001 8195 8202
21. H. Lewicki, A. Tishon, D. Homann, H. Mazarguil, F. Laval, V.C. Asensio, I.L. Campbell, S. DeArmond, B. Coon, C. Teng, J.E. Gairin, and M.B. Oldstone T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies J. Virol. 77 2003 3799 3808
22. D. Maimone, S. Gregory, B.G. Arnason, and A.T. Reder Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis J. Neuroimmunol. 32 1991 67 74
23. M. Martinez, E. Fernandez-Vivancos, A. Frank, M. De la Fuente, and A. Hernanz Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations Brain Res. 869 2000 216 219
24. M. Mogi, M. Harada, H. Narabayashi, H. Inagaki, M. Minami, and T. Nagatsu Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease Neurosci. Lett. 211 1996 13 16
25. T. Muller, D. Blum-Degen, H. Przuntek, and W. Kuhn Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease Acta Neurol. Scand. 98 1998 142 144
26. M. Otto, J. Wiltfang, L. Cepek, M. Neumann, B. Mollenhauer, P. Steinacker, B. Ciesielczyk, W. Schulz-Schaeffer, H.A. Kretzschmar, and S. Poser Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease Neurology 58 2002 192 197
27. J. Peltola, M. Hurme, A. Miettinen, and T. Keranen Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures Epilepsy Res. 31 1998 129 133
28. V.H. Perry, C. Cunningham, and D. Boche Atypical inflammation in the central nervous system in prion disease Curr. Opin. Neurol. 15 2002 349 354
29. S.B. Prusiner Shattuck lecture-neurodegenerative diseases and prions N. Engl. J. Med. 344 2001 1516 1526
30. A.B. Roberts, and M.B. Sporn Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta) Growth Factors 8 1993 1 9
31. M.K. Sharief, A. Green, J.P. Dick, J. Gawler, and E.J. Thompson Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease Neurology 52 1999 1289 1291
32. E. Tarkowski, L. Rosengren, C. Blomstrand, C. Wikkelso, C. Jensen, S. Ekholm, and A. Tarkowski Intrathecal release of pro- and anti-inflammatory cytokines during stroke Clin. Exp. Immunol. 110 1997 492 499
33. E. Tarkowski, K. Blennow, A. Wallin, and A. Tarkowski Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia J. Clin. Immunol. 19 1999 223 230
34. H. Tashiro, K. Dohura, and T. Iwaki Differential expression of transforming growth factor-beta isoforms in human prion diseases Neuropathol. Appl. Neurobiol. 24 1998 284 292
35. B. Van Everbroeck, E. Dewulf, P. Pals, U. Lubke, J.J. Martin, and P. Cras The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease Neurobiol. Aging 23 2002 59 64
36. R. Veerhuis, J.J. Hoozemans, I. Janssen, R.S. Boshuizen, J.P. Langeveld, and P. Eikelenboom Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2 Brain Res. 925 2002 195 203
37. A.E. Williams, A.M. van Dam, A.H.W.K. Man, F. Berkenbosch, P. Eikelenboom, and H. Fraser Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice Brain Res. 654 1994 200 206
38. A. Williams, A.M. Van Dam, D. Ritchie, P. Eikelenboom, and H. Fraser Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations Brain Res. 754 1997 171 180
39. I. Zerr, and S. Poser Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests APMIS 110 2002 88 98
40. I. Zerr, M. Bodemer, S. Racker, S. Grosche, S. Poser, H.A. Kretzschmar, and T. Weber Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease Lancet 345 1995 1609 1610
41. I. Zerr, M. Bodemer, O. Gefeller, M. Otto, S. Poser, J. Wiltfang, O. Windl, H.A. Kretzschmar, and T. Weber Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease Ann. Neurol. 43 1998 32 40
42. I. Zerr, M. Pocchiari, S. Collins, J.P. Brandel, J. de Pedro Cuesta, R.S. Knight, H. Bernheimer, F. Cardone, N. Delasnerie-Laupretre, N. Cuadrado Corrales, A. Ladogana, M. Bodemer, A. Fletcher, T. Awan, A. Ruiz Bremon, H. Budka, J.L. Laplanche, R.G. Will, and S. Poser Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease Neurology 55 2000 811 815
43. I. Zerr, W.J. Schulz-Schaeffer, A. Giese, M. Bodemer, A. Schroter, K. Henkel, H.J. Tschampa, O. Windl, A. Pfahlberg, B.J. Steinhoff, O. Gefeller, H.A. Kretzschmar, and S. Poser Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants Ann. Neurol. 48 2000 323 329